Protective effects of lipopolysaccharide preconditioning against nitric oxide neurotoxicity

J Neurosci Res. 2008 May 1;86(6):1277-89. doi: 10.1002/jnr.21594.

Abstract

We have characterized lipopolysaccharide (LPS) preconditioning-induced neuroprotective mechanisms against nitric oxide (NO) toxicity. Pretreatment of rat cortical cultures with LPS attenuated neurotoxicity of NO donors, including sodium nitroprusside (SNP) and diethylamine NONOate (NONOate). A transiently increased expression of endothelial nitric oxide synthase (eNOS) accompanied by an increase in NO production was observed during LPS preconditioning. Application of NOS inhibitors including L-N(5)-(1-iminoethyl)-ornithine (L-NIO) and L-nitroarginine methylester (L-NAME) abolished LPS-dependent protection against SNP toxicity. The LPS effect was also blocked by KT5823, an inhibitor of cGMP-dependent protein kinase (PKG). Consistently, application of 8-bromo-cyclic GMP (8-Br-cGMP), a slowly degradable cGMP analogue capable of PKG activation, was neuroprotective. LPS preconditioning resulted in a heightened neuronal expression of Bcl-2 protein that was abolished by L-NAME and KT5823, the respective inhibitors of NOS and PKG. Together, our results reveal the signaling cascade of "LPS --> eNOS --> NO --> cGMP/PKG --> Bcl-2" that might have contributed to the LPS protective effects in cortical neurons.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Blotting, Western
  • Brain / drug effects
  • Cells, Cultured
  • Cyclic GMP / metabolism
  • Immunohistochemistry
  • Ischemic Preconditioning / methods*
  • Lipopolysaccharides / pharmacology*
  • Microscopy, Confocal
  • Microscopy, Fluorescence
  • Nerve Degeneration / prevention & control*
  • Neurons / drug effects*
  • Nitric Oxide / toxicity*
  • Nitric Oxide Donors / pharmacology
  • Nitric Oxide Synthase Type III / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Signal Transduction / physiology*

Substances

  • Lipopolysaccharides
  • Nitric Oxide Donors
  • Proto-Oncogene Proteins c-bcl-2
  • Nitric Oxide
  • Nitric Oxide Synthase Type III
  • Cyclic GMP